Zobrazeno 1 - 10
of 222
pro vyhledávání: '"James Harwood"'
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background External randomised pilot trials aim to assess whether a future definitive randomised controlled trial (RCT) is feasible. Pre-specified progression criteria help guide the interpretation of pilot trial findings to decide whether,
Externí odkaz:
https://doaj.org/article/4350f1831f9142498f89c9e2c440fbae
Autor:
Caroline Struthers, James Harwood, Jennifer Anne de Beyer, Paula Dhiman, Patricia Logullo, Michael Schlüssel
Publikováno v:
BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background Th EQUATOR Network improves the quality and transparency in health research, primarily by promoting awareness and use of reporting guidelines. In 2018, the UK EQUATOR Centre launched GoodReports.org , a website that helps authors
Externí odkaz:
https://doaj.org/article/3a982e62eaea4f31b7a2e955b09bbb64
Autor:
James Harwood
Publikováno v:
Insights: The UKSG Journal, Vol 30, Iss 1, Pp 96-99 (2017)
James Harwood is the founder of Penelope, an automated tool that checks manuscripts and gives immediate feedback to authors before they submit to a journal. It adds comments to a manuscript, just as a real editor might, and tells authors what they mu
Externí odkaz:
https://doaj.org/article/530badfc2ae34211a5d770481cb26b8b
Autor:
James Harwood, Charlotte Albury, Jennifer Anne de Beyer, Zhaoxiang Bian, Yuting Duan, Shona Kirtley, Michael Schlussel, Lingyun Zhao, Gary S Collins
Background Despite endorsement by medical journals, reporting guidelines have only modestly affected reporting quality. We aimed to identify facilitators and barriers that researchers might encounter when using reporting guidelines. Methods We search
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1f0910beb8ed6fbd2421f34cc17d8d6
https://doi.org/10.21203/rs.3.rs-2238765/v1
https://doi.org/10.21203/rs.3.rs-2238765/v1
Autor:
Ruairi James Harwood Conway, William COOPER, Natalie Smith, Sonia Patole, Jenny Symonds, Anthony Edey, Nick A. Maskell, Anna Bibby
Publikováno v:
SSRN Electronic Journal.
Autor:
H. James Harwood, Jr., Stephen F. Petras, Dennis J. Hoover, Dayna C. Mankowski, Victor F. Soliman, Eliot D. Sugarman, Bernard Hulin, Younggil Kwon, E. Michael Gibbs, James T. Mayne, Judith L. Treadway
Publikováno v:
Journal of Lipid Research, Vol 46, Iss 3, Pp 547-563 (2005)
Diabetic dyslipidemia requires simultaneous treatment with hypoglycemic agents and lipid-modulating drugs. We recently described glycogen phosphorylase inhibitors that reduce glycogenolysis in cells and lower plasma glucose in ob/ob mice (J. Med. Che
Externí odkaz:
https://doaj.org/article/5ebbe43f58a84c83843fcaee4e9c9fbd
Autor:
Charles E. Chandler, Donald E. Wilder, Judith L. Pettini, Yvette E. Savoy, Stephen F. Petras, George Chang, John Vincent, H. James Harwood, Jr.
Publikováno v:
Journal of Lipid Research, Vol 44, Iss 10, Pp 1887-1901 (2003)
A microsomal triglyceride transfer protein (MTP) inhibitor, CP-346086, was identified that inhibited both human and rodent MTP activity [concentration giving half-maximal inhibition (IC50) 2.0 nM]. In Hep-G2 cells, CP-346086 inhibited apolipoprotein
Externí odkaz:
https://doaj.org/article/ab5935bef80d4de6bf899615697b8a90
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e103238 (2014)
Many electronic devices that we use in our daily lives provide inputs that need to be processed and integrated by our senses. For instance, ringing, vibrating, and flashing indicate incoming calls and messages in smartphones. Whether the presentation
Externí odkaz:
https://doaj.org/article/411d8cb1e8e94ffaab35c0b09d31fd98
Publikováno v:
Journal of Lipid Research, Vol 40, Iss 1, Pp 24-38 (1999)
The activity of HMG-CoA reductase (HMGR) is tightly regulated, in part through post-transcriptional mechanisms that are mediated by nonsterol products of mevalonate metabolism. Previous reports have suggested that these mediators are derived from far
Externí odkaz:
https://doaj.org/article/f3afd0aeba164b30b42afffb443fbd83
Autor:
Heather Kelley, Carine Beysen, William F. Westlin, Tess Schmalbach, Kathryn Stiede, Geraldine Harriman, Rosana Kapeller, H. James Harwood, Heather S. Blanchette, Wenyan Miao
Publikováno v:
Hepatology (Baltimore, Md.)
NDI-010976, an allosteric inhibitor of acetyl-CoA carboxylases (ACC) ACC1 and ACC2, reduces hepatic de novo lipogenesis (DNL) and favorably affects steatosis, inflammation, and fibrosis in animal models of fatty liver disease. This study was a random